EPISODE · Dec 7, 2022 · 27 MIN
EP. 232: Dr. Madeleine Oudin - Cancer and epilepsy researcher
from Teach the Geek: Public Speaking and Communication Skills for Technical Professionals · host Neil Thompson
Dr. Madeleine Oudin - Cancer and epilepsy researcher Dr. Madeleine Oudin, a biomedical engineering assistant professor, focuses her research on how cancer spreads throughout the body. She's also an epilepsy researcher. She organizes scientific meetings, too. In fact, she's doing one for the Tissue Engineering and Regenerative Medicine International Society (TERMIS). We chatted about her decision to become an academic, her choice of research interests, and what it takes to organize a conference. Hopefully she's well aware that a good conference must have snacks, and they must be plentiful. To learn more about Dr. Oudin, visit http://www.madeleineoudinlab.com/. __ TEACH THE GEEK teachthegeek.com/tips for public speaking tips Prefer video? Go to youtube.teachthegeek.com @teachthegeek (FB, Twitter) @_teachthegeek_ (IG, Tik Tok)
What this episode covers
Dr. Madeleine Oudin - Cancer and epilepsy researcher Dr. Madeleine Oudin, a biomedical engineering assistant professor, focuses her research on how cancer spreads throughout the body. She's also an epilepsy researcher. She organizes scientific meetings, too. In fact, she's doing one for the Tissue Engineering and Regenerative Medicine International Society (TERMIS). We chatted about her decision to become an academic, her choice of research interests, and what it takes to organize a conference. Hopefully she's well aware that a good conference must have snacks, and they must be plentiful. To learn more about Dr. Oudin, visit http://www.madeleineoudinlab.com/. __ TEACH THE GEEK teachthegeek.com/tips for public speaking tips Prefer video? Go to youtube.teachthegeek.com @teachthegeek (FB, Twitter) @_teachthegeek_ (IG, Tik Tok)
NOW PLAYING
EP. 232: Dr. Madeleine Oudin - Cancer and epilepsy researcher
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m